-
-
Call more information
660-596-2224 -
Authors: Dibash Kumar Das, PhD; Steven L. Shafer, MD, FASA ASA Monitor January 2024, Vol. 88, 1–7. The COVID-19 pandemic spurred unprecedented advances in many aspects of biomedicine. Among the most astonishing was the rapid development of mRNA vaccines, a technology for which Drs. Karikó and Weissman were awarded the 2023 Nobel Prize in Physiology or Medicine […]
Read MoreASA Monitor February 2024, Vol. 88, 10. A 68-year-old retired physician who has coronary artery disease is seen in the preoperative clinic before his scheduled coronary artery bypass graft. He asks about options for pain control, including nerve blocks and neuraxial techniques. According to a recent systematic review and meta-analysis, compared with general anesthesia, the use […]
Read MoreASA Monitor February 2024, Vol. 88, 16. Vaccine approval for chikungunya virus The U.S. Food and Drug Administration (FDA) has granted approval to Ixchiq, marking the first vaccine for chikungunya virus. Designed for individuals aged 18 and older at an elevated risk of chikungunya virus exposure, the vaccine addresses an emerging global health threat with over […]
Read MoreAuthor: Thomas H. Locke, MD, MPH ASA Monitor February 2024, Vol. 88, 19–21. Tribal nations have a unique relationship with the U.S. government, having ceded vast stretches of land and resources in exchange for specific treaty rights, one of which is health care services. The history of how this treaty obligation has been honored by the […]
Read MoreAuthor: Patsy Newitt Becker’s ASC Review Many physicians have experienced challenges stemming from Stark law, which bans them from making referrals for Medicare-payable health services if the physician or immediate family member has a financial relationship with the entity. Here are 10 key considerations to know: 1. Congress added an Anti-Kickback Statute to the Social […]
Read More